Heat shock proteins: Stress proteins with Janus-like properties in cancer

References

• Ellis RJ. Molecular chaperones: Assisting assembly in addition to folding. Trends Biochem Sci 2006; 31: 395–401
   PubMed Web of Science ®Google Scholar
• Ritossa F. A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 1962; 18: 571–573
   Google Scholar
• Ashburner M. The effects of heat shock and other stresses on gene activity: An introduction. Cold Spring Harbor laboratory Publications, Cold Spring Harbor Laboratory 1982
   Google Scholar
• Barnett TM, Altschuler CN, McDaniel CN, et al. Heat shock induced proteins in plant cells. Dev Genet 1980; 1: 331–340
   Google Scholar
• Bouche G, Amalric F, Caizergues-Ferrer M, et al. Effects of heat shock on gene expression and subcellular protein distribution in Chinese hamster ovary cells. Nucleic Acids Res 1979; 7: 1739–1747
   PubMed Web of Science ®Google Scholar
• Kelley PM, Schlesinger MJ. The effect of amino acid analogues and heat shock on gene expression in chicken embryo fibroblasts. Cell 1978; 15: 1277–1286
   PubMed Web of Science ®Google Scholar
• Lemeaux PG, Herendeen SL, Bloch PL, et al. Transient rates of synthesis of individual polypeptides in E. coli following temperature shifts. Cell 1978; 13: 427–434
   PubMed Web of Science ®Google Scholar
• Miller MJ, Xuong N-H, Geiduschek EP. A response of protein synthesis to temperature shift in the yeast Saccharomyces cerevisiae. Proc Nat Acad Sci USA 1979; 76: 1117–1121
   Web of Science ®Google Scholar
• Hightower LE, White FP. Cellular responses to stress: comparison of a family of 71–73-kilodalton proteins rapidly synthesized in rat tissue slices and canavanine-treated cells in culture. J Cell Physiol 1981; 108: 261–275
   PubMed Web of Science ®Google Scholar
• Georgopolis C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol 1993; 9: 601–634
   PubMedGoogle Scholar
• Schlossman DM, Schmid SL, Braell WA, et al. An enzyme that removes clathrin coats: Purification of an uncoating ATPase. J Cell Biol 1984; 99: 723–733
   PubMed Web of Science ®Google Scholar
• Pelham HR, Bienz M. A synthetic heat-shock promoter element confers heat-inducibility on the herpes simplex virus thymidine kinase gene. Embo J 1982; 1: 1473–1477
   PubMed Web of Science ®Google Scholar
• Sorger PK, Pelham HR. Yeast heat shock factor is an essential DNA-binding protein that exhibits temperature-dependent phosphorylation. Cell 1988; 54: 855–864
   PubMed Web of Science ®Google Scholar
• Wu C. Heat shock transcription factors: Structure and regulation. Ann Rev Cell Dev Biol 1995; 11: 441–469
   PubMed Web of Science ®Google Scholar
• Picard D, Khursheed B, Garabedian MJ, et al. Reduced levels of Hsp90 compromise steroid receptor action in vivo. Nature 1990; 348: 166–168
   PubMed Web of Science ®Google Scholar
• Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the Hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003; 228: 111–133
   PubMed Web of Science ®Google Scholar
• Connell P, Ballinger CA, Jiang J, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 2001; 3: 93–96
   PubMed Web of Science ®Google Scholar
• Li GC, Hahn GM. A proposed operational model for thermotolerance. Cancer Research 1981; 40: 4501–4508
   Google Scholar
• Subjeck JR, Sciandra JJ, Johnson RJ. Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol 1982; 55: 579–584
   PubMed Web of Science ®Google Scholar
• Li GC, Werb Z. Correlation between the synthesis of heat shock proteins and the development of thermotolerance in CHO fibroblasts. Proc Nat Academy of Sci USA 1982; 79: 3218–3222
   PubMed Web of Science ®Google Scholar
• Landry J, Bernier D, Chretien P, et al. Synthesis and degradation of heat shock proteins during the development and decay of thermotolerance. Cancer Research 1982; 42: 2457–2461
   PubMed Web of Science ®Google Scholar
• Sapareto S, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787–800
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Brunsting JF, Stege GJ, et al. Thermal protein denaturation and protein aggregation in cells made thermotolerant by various chemicals: Role of heat shock proteins. Exp Cell Res 1995; 219: 536–546
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Brunsting JF, Stege GJ, et al. Cells overexpressing Hsp27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochem Biophys Res Commun 1994; 204: 1170–1177
   PubMed Web of Science ®Google Scholar
• Buchner J. Hsp90 & Co. - A holding for folding. TIBS 1999; 24: 136–142
   PubMed Web of Science ®Google Scholar
• Wegele H, Muller L, Buchner J. Hsp70 and Hsp90 - A relay team for protein folding. Rev Physiol Biochem Pharmacol 2004; 151: 1–44
   PubMed Web of Science ®Google Scholar
• Gabai VL, Meriin AB, Mosser DD, et al. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem 1997; 272: 18033–18037
   PubMed Web of Science ®Google Scholar
• Gabai VL, Meriin AB, Yaglom JA, et al. Role of Hsp70 in regulation of stress-kinase JNK: Implications in apoptosis and aging. FEBS Lett 1998; 438: 1–4
   PubMed Web of Science ®Google Scholar
• Daugaard M, Rohde M, Jaattela M. The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett 2007; 581: 3702–3710
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment applications. Cell Stress Chaperones 2005; 10: 86–103
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Khaleque MA, Ciocca DR. Heat shock proteins in the progression of cancer. Springer, New York 2007; 7
   Google Scholar
• Calderwood SK, Khaleque MA, Sawyer DB, et al. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 2006; 31: 164–172
   PubMed Web of Science ®Google Scholar
• Wu G, Osada M, Guo Z, et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res 2005; 65: 758–766
   PubMed Web of Science ®Google Scholar
• Taira T, Sawai M, Ikeda M, et al. Cell cycle-dependent switch of up- and down-regulation of human Hsp70 gene expression by interaction between c-Myc and CBF/NF-Y. J Biol Chem 1999; 274: 24270–24279
   PubMedGoogle Scholar
• Tsutsumi-Ishii Y, Tadokoro K, Hanaoka F, et al. Response of heat shock element within the human Hsp70 promoter to mutated p53 genes. Cell Growth Diff 1995; 6: 1–8
   PubMedGoogle Scholar
• Madden SL, Galella EA, Zhu J, et al. SAGE transcript profiles for p53-dependent growth regulation. Oncogene 1997; 15: 1079–1085
   PubMed Web of Science ®Google Scholar
• Ghioni P, Bolognese F, Duijf PH, et al. Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Mol Cell Biol 2002; 22: 8659–8668
   PubMed Web of Science ®Google Scholar
• Agoff SN, Hou J, Linzer DI, et al. Regulation of the human Hsp70 promoter by p53. Science 1993; 259: 84–87
   PubMed Web of Science ®Google Scholar
• Khaleque MA, Bharti A, Sawyer D, et al. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 2005; 24: 6564–6573
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig EA. The heat shock proteins. Ann Rev Genet 1988; 22: 631–637
   PubMed Web of Science ®Google Scholar
• Bader AG, Kang S, Zhao L, et al. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005; 5: 921–929
   PubMed Web of Science ®Google Scholar
• Teng SC, Chen YY, Su YN, et al. Direct activation of Hsp90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem 2004; 279: 14649–14655
   PubMed Web of Science ®Google Scholar
• Wang Y, Theriault JR, He H, et al. Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells. J Biol Chem 2004; 279: 32651–32659
   PubMed Web of Science ®Google Scholar
• Hoang AT, Huang J, Rudra-Ganguly N, et al. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol 2000; 156: 857–864
   PubMed Web of Science ®Google Scholar
• Zou J, Guo Y, Guettouche T, et al. Repression of heat shock transcription factor HSF1 activation by Hsp90 (Hsp90 complex) that forms a stress-sensitive complex with HSF1. Cell 1998; 94: 471–480
   PubMed Web of Science ®Google Scholar
• Arrigo AP. Heat shock proteins as molecular chaperones. 2005; 21: 619–625, Med Sci (Paris)
   Google Scholar
• Farooqui-Kabir SR, Budhram-Mahadeo V, Lewis H, et al. Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a. Cell Death Differ 2004; 11: 1242–1244
   PubMed Web of Science ®Google Scholar
• Lee SA, Ndisang D, Patel C, et al. Expression of the Brn-3b transcription factor correlates with expression of Hsp27 in breast cancer biopsies and is required for maximal activation of the Hsp27 promoter. Cancer Res 2005; 65: 3072–3080
   PubMed Web of Science ®Google Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15–18
   PubMed Web of Science ®Google Scholar
• Tang D, Khaleque AA, Jones ER, et al. Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 2005; 10: 46–59
   PubMed Web of Science ®Google Scholar
• Beere HM. Stressed to death: Regulation of apoptotic signaling pathways by the heat shock proteins. Sci STKE 2001, 2001:RE1
   PubMedGoogle Scholar
• Nylandsted J, Brand K, Jaattela M. Heat shock protein 70 is required for the survival of cancer cells. Ann NY Acad Sci 2000; 926: 122–125
   PubMed Web of Science ®Google Scholar
• Tenniswood MP, Guenette RS, Lakins J, et al. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11: 197–220
   PubMed Web of Science ®Google Scholar
• Paul C, Manero F, Gonin S, et al. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 2002; 22: 816–834
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Nelson DA, White E. Exploiting different ways to die. Genes Dev 2004; 18: 1223–1226
   PubMed Web of Science ®Google Scholar
• Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 2004; 23: 2746–2756
   PubMed Web of Science ®Google Scholar
• Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: A specific form of programmed cell death?. Exp Cell Res 2003; 283: 1–16
   PubMed Web of Science ®Google Scholar
• Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43–52
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Oesterreich S, Chamness GC, et al. Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review. J Natl Cancer Inst 1993; 85: 1558–1570
   PubMed Web of Science ®Google Scholar
• Neckers L, Ivy SP. Heat shock protein 90. Curr Opin Oncol 2003; 15: 419–424
   PubMed Web of Science ®Google Scholar
• Pratt WB, Galigniana MD, Harrell JM, et al. Role of Hsp90 and the Hsp90-binding immunophilins in signalling protein movement. Cell Signal 2004; 16: 857–872
   PubMed Web of Science ®Google Scholar
• Zhou V, Han S, Brinker A, et al. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors. Anal Biochem 2004; 331: 349–357
   PubMed Web of Science ®Google Scholar
• Grammatikakis N, Vultur A, Ramana CV, et al. The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. J Biol Chem 2002; 277: 8312–8320
   PubMed Web of Science ®Google Scholar
• Pearl LH. Hsp90 and Cdc37–A chaperone cancer conspiracy. Curr Opin Genet Dev 2005; 15: 55–61
   PubMed Web of Science ®Google Scholar
• Scheibel T, Buchner J. The Hsp90 complex–A super-chaperone machine as a novel drug target. Biochem Pharmacol 1998; 56: 675–682
   PubMed Web of Science ®Google Scholar
• Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 2002; 8: S55–61
   PubMed Web of Science ®Google Scholar
• Neckers L, Lee YS. Cancer: The rules of attraction. Nature 2003; 425: 357–359
   PubMed Web of Science ®Google Scholar
• Kamal A, Thao L, Sensintaffar J, et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003; 425: 407–410
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Theriault JR, Gong J. Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol 2005; 35: 2518–2527
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Theriault JR, Gong J. How is the immune response affected by hyperthermia and heat shock proteins?. Int J Hyperthermia 2005; 21: 713–716
   PubMed Web of Science ®Google Scholar
• Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20: 395–425
   PubMed Web of Science ®Google Scholar
• Srivastava P. Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun 2003; 3: 4
   PubMedGoogle Scholar
• Srivastava PK. Immunotherapy of human cancer: Lessons from mice. Nat Immunol 2000; 1: 363–366
   PubMed Web of Science ®Google Scholar
• Belli F, Testori A, Rivoltini L, et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings. J Clin Oncol 2002; 20: 4169–4180
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Coppa J, Carrabba MG, et al. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res 2003; 9: 3235–3245
   PubMed Web of Science ®Google Scholar
• Srivastava PK. Therapeutic cancer vaccines. Curr Opin Immunol 2006; 18: 201–205
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, Restifo NP. Cancer Immunotherapy: Moving beyond current vaccines. Nature Medicine 2004; 10: 909–915
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, Chen X, et al. Hsp110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol 2003; 171: 4054–4061
   PubMed Web of Science ®Google Scholar
• Segal BH, Wang XY, Dennis CG, et al. Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today 2006; 11: 534–540
   PubMed Web of Science ®Google Scholar
• Rock KL, Hearn A, Chen CJ, et al. Natural endogenous adjuvants. Springer Semin Immunopathol 2005; 26: 231–246
   PubMed Web of Science ®Google Scholar
• Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol 2006; 18: 85–91
   PubMed Web of Science ®Google Scholar
• Zeng Y, Graner MW, Katsanis E. Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunol Immunother 2006; 55: 329–338
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Bharti A, Khaleque A, et al. Enhanced immunogenicity of Hsp70 peptide complexes from DC-tumor fusion cells requires Myd-88. J Immunol 2006, (in press)
   PubMed Web of Science ®Google Scholar
• Rosenberg SA. Shedding light on tumor immunotherapy of cancer. NEJM 2004; 350: 1461–1463
   PubMed Web of Science ®Google Scholar
• Daniels GA, Sanchez-Perez L, Diaz RM, et al. A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol 2004; 22: 1125–1132
   PubMed Web of Science ®Google Scholar
• Calderwood SK. Chaperones and slow death–A recipe for tumor immunotherapy. Trends Biotechnol 2005; 23: 57–59
   PubMed Web of Science ®Google Scholar
• Engelhard VH, Bullock TN, Colella TA, et al. Antigens derived from melanocyte differentiation proteins: Self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev 2002; 188: 136–146
   PubMed Web of Science ®Google Scholar
• Todryk S, Melcher AA, Hardwick N, et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 1999; 163: 1398–1408
   PubMed Web of Science ®Google Scholar
• Huang XF, Ren W, Rollins L, et al. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Cancer Res 2003; 63: 7321–7329
   PubMed Web of Science ®Google Scholar
• Repasky E, Issels R. Physiological consequences of hyperthermia: Heat, heat shock proteins and the immune response. Int J Hyperthermia 2002; 18: 486–489
   PubMed Web of Science ®Google Scholar
• Mambula SS, Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 2006; 177: 7849–7857
   PubMed Web of Science ®Google Scholar
• Evans SS, Wang WC, Bain MD, et al. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 2001; 97: 2727–2733
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Clancy KA, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 2006; 12: 1299–1308
   Google Scholar
• Ciocca DR, Frayssinet P, Cuello-Carrión FD. A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients. Cell Stress Chaperones 2007; 12: 33–43
   PubMed Web of Science ®Google Scholar
• Bonorino C, Souza AP. Hsp70 in tumors: Friend or foe?. Heat shock proteins in biology and medicine, SK Calderwood, MY Sherman, DR Ciocca. Springer, New York 2007
   Google Scholar